semaglutide and concerta FDA issues warning about some compounded versions of for diabetes, weight loss Weight loss drug semaglutide may

Most hair loss from GLP-1 medications is short-term

Phentermine is FDA-approved for short-term use , generally no longer than 12 weeks (some studies extend to about six months), and it is a Schedule IV controlled substance meaning it has a proven but low potential for abuse and an accepted medical use

For all chronic illnesses, from rheumatoid arthritis to asthma to high blood pressure, patients usually relapse as soon as their treatment stops

Best to reduce the dose and frequency over several weeks time to avoid rebound reflux symptoms

compounded options but includes brand-name medication and medical oversight